Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SusmedTSE:4263 +0.52%60 Gross Margin % is 94.70% as of Mar. 2026, which is 2% below its 10-year median of 96.58. GuruFocus rates TSE:4263 with a GF Score™ of 60/100 and a GF Value™ of 円904.97 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Susmed ranks better than 97.62% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Susmed's Gross Profit for the
three
months ended in Mar. 2026 was 円218.5 Mil. Susmed's Revenue for the
three
months ended in Mar. 2026 was 円230.7 Mil. Therefore, Susmed's Gross Margin % for the quarter that ended in Mar. 2026 was 94.70%.
The historical rank and industry rank for Susmed's Gross Margin % or its related term are showing as below:
TSE:4263'
s Gross Margin % Range Over the Past 10 Years
Min: 91.55 Med: 96.58 Max: 98.49
Current: 96.5
During the past 7 years, the highestGross Margin % of Susmed was 98.49%. The lowest was 91.55%. And the median was 96.58%.
TSE:4263's Gross Margin % is ranked better than 97.62% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.25
vs TSE:4263: 96.50
Susmed had a gross margin of 94.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Susmed was 0.80% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Susmed had a gross margin of 94.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Susmed Gross Margin % Related Terms
Susmed Gross Margin % Historical Data
* Premium members only.
The historical data trend for Susmed's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4263 vs VEEV, BTSG, HQY: Gross Margin % Comparison
For the Health Information Services subindustry, Susmed's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Susmed Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Susmed's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Susmed's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Susmed (TSE:4263) has a Gross Margin % of 94.70% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Susmed and its competitors. This is near median its historical median of 96.58. Over the past decade, Susmed's Gross Margin % has ranged from 91.55 to 98.49. According to the industry distribution chart, Susmed ranks #15 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 2.4%.
Is Susmed's Gross Margin % too high?
Susmed's current Gross Margin % of 94.70% is near median its 10-year median of 96.58. Over the past 10 years, this metric has ranged from a low of 91.55 to a high of 98.49. The Healthcare Providers & Services industry median Gross Margin % is 40.25. Susmed's value of 94.70% is 135.3% above this industry median. Based on the distribution chart, Susmed ranks #15 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Susmed has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Susmed's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Susmed ranks #15 out of 629 companies for Gross Margin %. This places Susmed in the top 2% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.25. Susmed's value of 94.70% is 135.3% above this benchmark. Historically, Susmed's own Gross Margin % has ranged from 91.55 to 98.49 over the past decade. While the company's 10-year median is 96.58 vs. the industry median of 40.25, Susmed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.25, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Susmed's current Gross Margin % of 94.70% is 135.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Susmed and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Susmed's current Gross Margin % is 94.70%, which is near median its own 10-year median of 96.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Susmed stock overvalued right now?
Based on GuruFocus' analysis, Susmed (TSE:4263) is currently considered Possible Value Trap. The stock's GF Value™ is 円904.97, compared to a current price of 円576.00 — trading 36.4% below its estimated fair value. The current Gross Margin % is 94.70%, which is near median its 10-year median of 96.58 and 135.3% above the Healthcare Providers & Services industry median of 40.25. Susmed's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Susmed (TSE:4263), the current Gross Margin % is 94.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Susmed (TSE:4263) Overvalued in 2026?
Based on GuruFocus' analysis, Susmed stock appears to be undervalued.
The current stock price of 円576.00 is trading 36.4% below its estimated GF Value™ of 円904.97.
GuruFocus considers Susmed to be Possible Value Trap.
Key valuation signals for TSE:4263:
Gross Margin %: 94.70% (near median its 10-year median of 96.58)
GF Value™: 円904.97 vs. price of 円576.00 (36.4% below fair value)
Industry Position: 135.3% above the Healthcare Providers & Services median (#15 of 629)
No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
60GF Score
Get the complete analysis for TSE:4263
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4263 has been successfully added to your 
